Claritev (CTEV) Stock Analysis & AI Equity Report

Medical - Healthcare Information Services USD Explore free reports

Claritev (CTEV) overview

Claritev (CTEV) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 965m and operating profit of USD 28.8m; the year-end share price was 42.75 USD and market capitalisation was USD 708m. Claritev is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Claritev's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD -174mFY 2025
Share price42.75 USDFY 2025 year end
RevenueUSD 965mFY 2025
Operating profitUSD 28.8mFY 2025
Net earningsUSD -284mFY 2025
Market capitalisationUSD 708mFY 2025 year end

About Claritev

Claritev provides technology, data, analytics and services to organizations across the U.S. healthcare system. Its offerings address out-of-network cost management, payment integrity, billing and payment accuracy, and in-network payment and revenue integrity. The company serves healthcare payers, providers and other organizations, using claims experience and data-driven insights to help them assess costs, pricing and payment dynamics.

Generate the Claritev report

Claritev is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Claritev and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Claritev

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.